Baskhanbio Pharma Inc. (XKON: 354390)
South Korea
· Delayed Price · Currency is KRW 4,085.00
-15.00 (-0.37%)
Jan 23, 2025, 9:00 AM KST
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 29.48 billion as of January 29, 2025. Its market cap has decreased by -34.07% in one year.
Market Cap
29.48B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,085.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 29.48B, a decrease of -64.41%. That is a compound annual growth rate of -33.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 24, 2025 | 29.48B | -2.10% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 356.70T |
| SK hynix | 152.28T |
| LG Energy Solution | 82.72T |
| Samsung Biologics Co.,Ltd. | 77.37T |
| Hyundai Motor Company | 45.23T |
| Kia Corporation | 39.63T |
| Celltrion | 38.22T |
| KB Financial Group | 33.29T |